papaverine has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, SC | 1 |
1 other study(ies) available for papaverine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide
Article | Year |
---|---|
Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
Topics: Animals; Dose-Response Relationship, Drug; Esophageal Sphincter, Lower; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Oligopeptides; Papaverine; Receptor, PAR-1; Receptor, PAR-2; Receptors, Proteinase-Activated; Thrombin; Trypsin | 2007 |